The gSageTMCancerAI Platform supports every decision point in cancer care.
Every input is typed, organized, and linked into one longitudinal record; the single source of truth every workflow reads from.
Everything the patient needs between visits. Always connected to the oncologist’s Casebook, always current.
A molecular replica of each patient’s tumor that ranks every therapy before a single dose.
Proprietary cancer sequencing panels built specifically for the Digital Twin.
From first-line therapy to trial matching, resistance, and toxicity, every call in cancer care is made simple and explainable
Ranked regimens with simulated response, resistance trajectory, and sequencing implications before any dose.
Continuous background matching against open trials eligibility surfaced the moment it is met.
Resistance trajectory modeled before treatment begins, recalculated continuously as ctDNA and imaging arrive.
Pharmacogenomic flags and adverse-event early-warning classifiers running in parallel. Risk surfaced before it becomes harm
The Casebook Tumor Board brings a multidisciplinary view to every complex case in minutes.
Essential Healthcare guidelines rec- onciled with this patient’s molecular reality in the consultation room.
Every new lab, scan, or report re-runs the twin updated recommendations with the reason for every change.
De-identified outcomes power bio- marker studies and trial enrichment. Fully governed, separate from clinical workflows.
Request a demo or explore the science behind the platform.